Recent Finacing
Recent Raise
Aegera Therapeutics is a clinical-stage biotech developing targeted therapeutics for oncology and diabetic neuropathy, with lead programs AEG35156 and AEG33773 in Phase 2 trials in North America and Europe.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor